Tag
Bliss GVS Pharma Limited
5 articles
Anupam Rasayan has significantly altered the ownership structure of Bliss GVS Pharma through a series of transactions, culminating in the acquisition of a controlling 48.2% stake for approximately ₹300 crore. The deal, financed through a combination of debt and non-voting instruments, creates a ₹4,000 crore integrated platform and brings finished dosage formulation capabilities to Anupam Rasayan. While an open offer to acquire an additional 26% stake yielded a minimal response, the core transaction is progressing, with the appointment of new directors and reclassification of promoters to the public category. Investors should monitor the integration of Bliss GVS and the utilization of its manufacturing assets, currently operating at 30% capacity, to assess the long-term value creation potential.
Bliss GVS Pharma Board Approves Two ESOP Schemes
Board approved Senior Executive ESOP 2026 for up to 2.49% of equity shares (26.5 lakh shares).
Board approved Employee ESOP 2026 for up to 4.42% of equity shares (47 lakh shares).
Both schemes feature
Anupam Rasayan Clarifies Bliss GVS Pharma Acquisition Details
Anupam Rasayan issues clarification correcting typographical errors in its previous disclosure regarding acquisition of Bliss GVS Pharma shares.
Confirms PAC acquired 5,09,84,595 equity shares represe
Bliss GVS Promoters Reclassified to Public Category
Board approved reclassification of 27 promoter group entities to public category post takeover completion.
Anupam Rasayan India Limited acquired control via share purchase agreement and open offer.
To
Anupam Rasayan Bliss GVS Open Offer 1,669 Shares Acquired
Anupam Rasayan India Limited's open offer for 26% of Bliss GVS Pharma concluded with only 1,669 shares tendered and accepted, a tiny fraction of the 2.77 crore shares offered.
The acquirer paid ₹299 p
Bliss GVS Open Offer Addendum Adds Mates Visa as PAC
Bliss GVS Pharma received an addendum to an open offer from Anupam Rasayan, designating Mates Visa Consultancy as a person acting in concert (PAC).
The addendum, dated July 17, 2026, discloses Mates V